Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001705562-26-000002
Filing Date
2026-05-01
Accepted
2026-05-01 16:11:03
Documents
1
Period of Report
2026-05-01

Document Format Files

Seq Description Document Type Size
1 form4-05012026_080500.html 4  
1 form4-05012026_080500.xml 4 4355
  Complete submission text file 0001705562-26-000002.txt   5993
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ALTIMMUNE, INC. 910 CLOPPER ROAD, SUITE 201S GAITHERSBURG MD 20878
Business Address
Hodges Philip (Reporting) CIK: 0001705562 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 26932617